Navigation Links
BioMotiv Names New Chief Executive Officer
Date:8/21/2012

CLEVELAND, Aug. 21, 2012 /PRNewswire/ -- BioMotiv, LLC, today announced the appointment of Baiju R. Shah as its new chief executive officer, and as a member of its Board of Managers, effective September 1, 2012.  Currently, Mr. Shah is president and chief executive officer of BioEnterprise, a business acceleration initiative and partnership among leading Cleveland-area hospitals and health systems.

"We are excited that Baiju Shah will be leading BioMotiv, a key part of the Harrington Project for Discovery and Development," said Achilles A. Demetriou, MD, PhD, BioMotiv board chairman and chief operating officer of University Hospitals (UH).  "With his knowledge of the life science industry, healthcare, business development and the importance of medical innovation, he is the perfect person to lead and grow this unique organization."

BioMotiv has designed a next generation business model that facilitates efficient and profitable development of multiple, early-stage drug candidate programs with the objective of out-licensing significantly enhanced assets to biopharmaceutical companies or venture firms.

"A new business model is just what the biotech industry needs," said Mr. Shah. "In my new role at BioMotiv, we will be developing just such a model, one closely aligned with physician-scientists who are eager to participate in the discovery and development process to bring novel therapies to patient care."

BioMotiv is a part of The Harrington Project for Discovery and Development, a first-of-its-kind $250 million initiative announced by UH in February.  BioMotiv is continuing its plans to raise $100 million in total initial capital as it builds a portfolio of breakthrough discoveries in-licensed from academic medical centers, research institutions, and other sources.

Prior to his decade of work with BioEnterprise, Mr. Shah, a Cleveland native, played a leading role in the
'/>"/>

SOURCE BioMotiv
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
3. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
4. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
5. Bausch + Lomb Names John Barr Global President Surgical
6. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
7. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
8. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
9. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
10. MedVantx Names New VP Employer Solutions and Workplace Health
11. Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... WASHINGTON , May 22, 2015  The ... certain diagnosed victims of mesothelioma get the best ... making certain individuals with this rare cancer caused ... the most up-to-date information related to treatment options ... information please call the Mesothelioma Victims Center anytime ...
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/5x377m/north_american ) has announced the addition of ... by Type (Ankle Replacement, Digit Replacement, Elbow ... - Forecast to 2019" report to ... market for knee replacement was valued at ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... in a physicians office practice, can be instrumental ... ailments; UTIs, diabetes, several cancers, metabolic disorders, cardiovascular ... for urinalysis tests is well in excess of ... For such a fundamental, extensive and economically significant ...
... large multi-site lab faced challenges with manual document ... were exacerbated by staff shortages and growing test ... was essential for accreditation compliance and also to ... manage documents. They therefore assessed a variety of ...
Cached Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Choosing Lab Quality Management Software 2Choosing Lab Quality Management Software 3Choosing Lab Quality Management Software 4
(Date:5/24/2015)... Pacific Prime has announced that they have launched the second ... of individual international health insurance. Titled: The Cost of Health Insurance ... health insurance in six top expat destinations, which are also popular ... Kong , Singapore , China , ... UK , Article 2 presents an in-depth look at ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific ... compliance issues that may have raised the risk of ... just posted an article on the research. Click ... found airborne asbestos levels well above OSHA safety guidelines ... 2011. , “Asbestos compliance sampling data associated with the ...
(Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Jay Krihak as its head of programmatic strategy ... its expertise and leadership position in the data ... sectors. , Krihak is an experienced, award-winning agency ... led sales planning teams for mobile platform Jumptap. ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... 23, 2015 A live auction will be ... hospitals, surgery centers and other medical facilities around the United ... endoscopy, lab, radiology, surgery, anesthesia, exam and much more. ... and Thursday, May 28 starting at 9:00am CDT each day. ... N. 25th Avenue, Melrose Park, IL 60160. Anyone can ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... Amgen (Nasdaq: AMGN ) will present ... on Monday, May 18, 2009 at the InterContinental, Boston, ... and Chief Executive Officer Kevin Sharer will present. Live ... Internet and can be accessed from Amgen,s Web site, ...
... treatment prolonged survival in older women, study finds , ... with early-stage breast cancer do better after standard chemotherapy ... a new study finds. , "After three years, 85 ... and 68 percent of people who received capecitabine ...
... ("SCA") today announced that it will host an investor ... May 19, 2009, to discuss its 2009 first quarter ... ) Please go to SCA,s Intralinks website to obtain ... or contact Kathleen Vojta at 205-545-2693 or by e-mail ...
... Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: ... for disease indications with large markets, today announced its ... Selected Highlights, -------------------, ... 2009 and up to the date of this press,release, ...
... VIEW, Calif., May 13 MAP Pharmaceuticals, Inc. (Nasdaq: ... at the Deutsche Bank Securities 34th Annual Health ... (ET) in Boston, MA.A live webcast of the presentation will ... website at http://www.mappharma.com . A replay will also be ...
... Katherine Borden, at the Institute for Research in Immunology ... shown that a common anti-viral drug, ribavirin, can be ... the journal Blood (First Edition), the study ... gene in patients. This gene is dysregulated in 30 ...
Cached Medicine News:Health News:Chemotherapy Superior to New Drug for Early Breast Cancer 2Health News:Chemotherapy Superior to New Drug for Early Breast Cancer 3Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 2Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 3Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 4Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 5Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 6Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 7Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 8Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 9Health News:Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results 10Health News:Novel therapy may prove effective in treatment of 30 percent of cancers 2
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
Designed to lift corneal cap/flap during corneal lamellar surgery...
Pre-expanded for convenience; no need to pre-soak and fan. Lint-free PVAmaterial...
Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
Medicine Products: